Categorías
-
Adhesives
6
Amines
98
Amino Acids
184
Analytical Reagents
702
Antibiotics
254
Bioactive Small Molecules
735
Aroma Chemicals
212
Biochemicals
1040
Boronic Acids
4
Buffers
97
Building Blocks
1901
Carbohydrates
179
Catalysts
108
Chiral Compounds
59
Coccus nucifera oil
0
Detergents
59
Diagnostic Raw Materials
261
Flavours and Fragrance Materials
212
Fluorinated Products
50
Furans
6
Gases in Solution
49
Grignard Reagents
26
HPLC Reagents
8
Imidazoles
17
Indoles
42
Inorganic Chemicals
341
Ion-Pair Reagents
24
Ligands
80
Organics
1417
Oxazoles
3
Peptide Reagents
90
Phenols
50
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
57
Pyrimidines
31
Quaternary Ammonium salts
43
Reagents
106
Research Organics & Inorganics
791
Salts
296
Sealing Compounds
1
Sherclin
1
Solvents
127
Stains & Indicators
301
Sugars
63
Tailor-made solutions
1
Testing Standards
4
Uncategorised
58
Water Analysis
12
Bosentan hydrate
(20114584 | 157212-55-0)
CAS: | 157212-55-0 |
---|---|
Fórmula molecular: | C27H29N5O6S . H2O |
Peso molecular: | 569.63 |
Disponibilidad: | En stock |
---|---|
Descargas: | | |
20114584-1g | 1g | £318.30 | |
Pedido bulk |
20114584-1g | 1g | €445.70 | |
Pedido bulk |
20114584-1g | 1g | $477.50 | |
Pedido bulk |
Ficha de datos de seguridad
Certificado de análisis
Detalle del producto
Product Code | 20114584 | ||||
Product Name | Bosentan hydrate | ||||
Categories | Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 157212-55-0 | ||||
Molecular Formula | C27H29N5O6S . H2O | ||||
Molecular Weight | 569.63 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 29359090 |
Especificaciones del producto
Water | 2 - 4% | ||||
Impurity A | <0.5% | ||||
Impurity B | <0.5% | ||||
Heavy metals | <10ppm | ||||
Impurity C | <0.5% | ||||
Ethanol | <0.5% | ||||
Methanol | <0.3% | ||||
Residue on Ignition | <0.1% | ||||
Toluene | <0.089% | ||||
Appearance | White to yellowish solid | ||||
Purity HPLC | >99% |
Información de seguridad
Pictograms |
|
||||
Signal word | warning | ||||
Hazard statements |
|
||||
Precautionary statements |
|